skip to main content
Refinado por: tipo de recurso: Anais de Congresso remover nível superior: Recursos Online remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
NT-pro BNP and diastolic dysfunction by echocardiography predicts cardiovascular outcomes in patients with heart failure and preserved systolic function
Material Type:
Ata de Congresso
Adicionar ao Meu Espaço

NT-pro BNP and diastolic dysfunction by echocardiography predicts cardiovascular outcomes in patients with heart failure and preserved systolic function

Grewal, J ; Mckelvie, R ; Persson, H ; Tait, P ; Carlsson, J ; Swedberg, K ; Ostergren, J ; Lonn, E

EUROPEAN HEART JOURNAL, 2007, Vol.28, p.271 [Periódico revisado por pares]

Texto completo disponível

2
The selective delta opioid agonist SNC 80 potentiates cocaine-induced locomotor activity without a concomitant increase in dopamine release in the nucleus accumbens
Material Type:
Ata de Congresso
Adicionar ao Meu Espaço

The selective delta opioid agonist SNC 80 potentiates cocaine-induced locomotor activity without a concomitant increase in dopamine release in the nucleus accumbens

Swanhagen, AC ; Kosowski, AR ; Swedberg, MDB ; Liljequist, S

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, Vol.14, p.S344 [Periódico revisado por pares]

Texto completo disponível

3
Impact of candesartan in preventing myocardial infarction: Results of the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) programme
Material Type:
Ata de Congresso
Adicionar ao Meu Espaço

Impact of candesartan in preventing myocardial infarction: Results of the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) programme

Demers, C ; McMurray, JJ ; Swedberg, K ; McKelvie, RS ; Olofsson, B ; Ostergren, J ; Solomon, S ; Yusuf, S

CIRCULATION, 2004, Vol.110 (17), p.514 [Periódico revisado por pares]

Texto completo disponível

4
Reduction in all-cause mortality and morbidity with candesartan in patients with chronic heart failure and systolic left ventricular dysfunction: Results of the CHARM low
Material Type:
Ata de Congresso
Adicionar ao Meu Espaço

Reduction in all-cause mortality and morbidity with candesartan in patients with chronic heart failure and systolic left ventricular dysfunction: Results of the CHARM low

Young, JB ; Swedberg, K ; Dunlap, ME ; Pfeffer, MA ; Probstfield, JL ; Granger, CB ; McKelvey, RS ; McMurray, MJV ; Michaelson, EL ; Olofsson, B ; Ostergren, J ; Yusuf, S

JOURNAL OF CARDIAC FAILURE, 2004, Vol.10 (4), p.S76 [Periódico revisado por pares]

Texto completo disponível

5
Effect of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the consensus trial)
Material Type:
Ata de Congresso
Adicionar ao Meu Espaço

Effect of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the consensus trial)

SWEDBERG, K ; ENEROTH, P ; KJEKSHUS, J ; SNAPINN, S ; CODY, R ; FRANCIS, G ; HIRSCH, A

The American journal of cardiology, 1990, Vol.66 (11), p.40D-45D [Periódico revisado por pares]

New York, NY: Elsevier

Texto completo disponível

Buscando em bases de dados remotas. Favor aguardar.